Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-27 @ 9:52 PM
Study NCT ID:
NCT04452292
Status:
COMPLETED
Last Update Posted:
2023-05-17
First Post:
2020-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma
Sponsor:
Charles Kunos
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-20-GI-112-PMC; MULTI-37
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |